|
|
Tour De France
Doping at the Tour de France refers to the use of illegal drugs in the
annual road bicycle race, the Tour de France. There have been allegations of
doping in the Tour de France since 1903. Early Tour riders were said to have
consumed alcohol and used ether, among other substances, as a means of dulling
the pain of competing in endurance cycling.
[1] As time went by, riders began using substances as a means of
increasing performance rather than dulling the senses, and organizing bodies
such as the Tour and the International Cycling Union (UCI), as well as
government bodies, enacted policies to combat the practice. One of the first famous doping scandals occurred on July 13, 1967. British
cyclist Tom Simpson died climbing Mont Ventoux following usage of amphetamines,.
The amphetamines allowed Simpson to pass his level of endurance and succumb to
excessive exhaustion.[2] This occurred
before official anti-doping tests, which promptly started the following year.[3] The 1998 Tour de France, dubbed the "Tour of Shame", is considered the most
scandal-ridden modern Tour. On July 8, 1998, a major scandal erupted after
French Customs arrested Willy Voet, one of the seigneurs for the Festina cycling
team, for the possession of illegal prescription drugs, including narcotics,
erythropoietin (EPO), growth hormones, testosterone, and amphetamines. (Voet
later described many common doping practices in his book, Massacre à la
Chaîne[4].) Two weeks later, on
July 23, 1998, French police raided several teams in their hotels and found
doping products in the possession of the TVM team. Further raids were
threatened. As news of the police action spread among the riders during the
seventeenth stage of the Tour, they staged a "sit-down strike" and refused to
continue. After mediation by Jean-Marie Leblanc, the Director of the Tour,
police agreed to limit the most heavy-handed tactics and the riders agreed to
continue. Many riders and teams had already abandoned, however, and only 111
riders completed the stage, riding without race numbers and at a leisurely pace.
In a 2000 criminal trial, it became clear that the management and health
officials of the Festina team had deliberately organized doping within the team.
Richard Virenque, a top Festina rider, finally confessed at the trial after
being ridiculed for maintaining that if he was doping he was somehow not
consciously aware of it ("à l'insu de mon plein gré") In the years following the Festina scandal, anti-doping measures were put
into effect by race organizers and the UCI, including more frequent testing of
riders and new tests for blood doping (transfusions and EPO use). The World
Anti-Doping Agency (WADA) was also created to help aid governments in
anti-doping. Evidence of doping persisted, however, and in 2004 a new wave of credible
doping allegations came forth. In January, Philippe Gaumont, a rider with the
Cofidis team, told investigators and the press that doping with steroids, human
growth hormone, EPO, and amphetamines was endemic to the team. In June, British
cyclist David Millar, also of Cofidis, and reigning time trial World Champion at
the time, was detained by French police. His apartment was searched and two used
EPO syringes were found. Finally, Jesus Manzano, a Spanish rider then recently
dismissed by the Kelme team, told Madrid sports newspaper AS in bitter tones and
lurid detail how he had been forced by his former team to take banned substances
and how they had taught him to evade detection. The Kelme team itself was
ultimately a casualty of the disclosures, which Manzano judged to be “an eye for
an eye and a tooth for a tooth.”[5] Doping controversy has surrounded seven-time Tour champion Lance Armstrong
for some time, although there has never been evidence sufficient for him to be
sanctioned by any sports authority. In part, the suspicion has arisen from his
association with Italian physician Michele Ferrari, who has confessed to
prescribing doping agents to athletes. There have also been allegations by
former assistant, Mike Anderson, that Armstrong used Androstenine. This resulted
in a law suit against Anderson and a counter suit against Armstrong.
[6] In late August 2005, one month
after Lance Armstrong's seventh consecutive Tour victory, the French sports
newspaper ‘’L'Equipe’’ claimed to have uncovered evidence that Armstrong had
used EPO in the 1999 Tour de France.[7]
The claim was based on testing of archived urine samples by the French National
Laboratory for Doping Detection (LNDD) for research purposes. Armstrong denied
using EPO, and the UCI did not sanction him because of the lack of a duplicate
sample. The UCI has confirmed that it was its own lead doctor Mario Zorzoli who
in fact leaked the 15 forms tying Armstrong to the positive tests to L'equipe.
In the same year, Armstrong tested positive for a glucocorticosteroid hormone.
Armstrong explained he had used an external "cortisone" ointment in order to
treat a saddle sore, and produced a prescription for it. The amount detected was
well below the "positive" threshold and was consistent with the amount that
would be used for a topical skin cream, but UCI rules require that prescriptions
be shown to sports authorities in advance of use. In 2006, several riders, including Jan Ullrich and Ivan Basso, were barred
from competing on the eve of the race amid allegations made by the Spanish
police as a result of their Operacion Puerto investigation.[8]
In total 17 riders have been excluded in the scandal. Teams and members include: On July 27, 2006 the Phonak Cycling Team announced that Floyd Landis, the
declared winner of the 2006 Tour, tested positive in a drug test given to him
after Stage 17, as part of the Tour's standard doping precautions. He tested
positive for an abnormally high ratio of the hormone testosterone to
epitestosterone during Stage 17 of the race. On the same day the allegations
were made public, Landis denied doping in order to win the 2006 Tour de France. Many different doping agents have been used to enhance performance in the
Tour de France. Recently the most common used has been erythropoietin, or EPO.
It is a red blood cell stimulating hormone that is virtually undetectable a few
days after injection, while its effects last for several weeks. EPO doping is
believed by many to be almost universal among Tour riders, and the UCI has been
criticized—by WADA among others—for not taking stronger action to detect EPO
use. Scientific experts have cautioned, however, that technical flaws in the
current urine test for EPO may be resulting in false positive results.[11]
Text and images
from Wikipedia, the free
encyclopedia. under the
|
|